Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients
Bioheart's TGI 1200 System is a fully-automated, point-of-care system that recovers potentially regenerative cells from a patient's own fat in about an hour, with minimal operator intervention. No tissue pre-processing is required. The system, distributed by Bioheart under an exclusive license from Tissue Genesis, Inc., accepts adipose (fat) tissue from the same device used for liposuctioning the tissue from the patient. The compact desktop unit readily fits into any clinical environment and uses preconfigured disposables for quick and easy assembly.
The unit will be kept by Philadelphia BioMed at the University of Jordan's Cell Therapy Centre, under the direction and supervision of Dr. Abdallah Al-Abbadi, MD, who is Professor of Hematology at the Faculty of Medicine, for use by vascular surgeons in chronic limb ischemia patients to improve blood circulation of the limbs and prevent leg amputation. Peripheral vascular disease commonly affects the arteries supplying the leg and is mostly caused by atherosclerosis. Further reduction in blood flow causes ischemic pain at rest, which affects the foot leading to ulceration and gangrene.
Continued at the link below
http://www.tradingmarkets.com/.site/news/Stock News/2125677/
Bioheart's TGI 1200 System is a fully-automated, point-of-care system that recovers potentially regenerative cells from a patient's own fat in about an hour, with minimal operator intervention. No tissue pre-processing is required. The system, distributed by Bioheart under an exclusive license from Tissue Genesis, Inc., accepts adipose (fat) tissue from the same device used for liposuctioning the tissue from the patient. The compact desktop unit readily fits into any clinical environment and uses preconfigured disposables for quick and easy assembly.
The unit will be kept by Philadelphia BioMed at the University of Jordan's Cell Therapy Centre, under the direction and supervision of Dr. Abdallah Al-Abbadi, MD, who is Professor of Hematology at the Faculty of Medicine, for use by vascular surgeons in chronic limb ischemia patients to improve blood circulation of the limbs and prevent leg amputation. Peripheral vascular disease commonly affects the arteries supplying the leg and is mostly caused by atherosclerosis. Further reduction in blood flow causes ischemic pain at rest, which affects the foot leading to ulceration and gangrene.
Continued at the link below
http://www.tradingmarkets.com/.site/news/Stock News/2125677/